Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 16;24(2):314.
doi: 10.3390/molecules24020314.

Chiral Derivatives of Xanthones with Antimicrobial Activity

Affiliations
Review

Chiral Derivatives of Xanthones with Antimicrobial Activity

Joana Araújo et al. Molecules. .

Abstract

According to the World Health Organization, the exacerbated use of antibiotics worldwide is increasing multi-resistant infections, especially in the last decade. Xanthones are a class of compounds receiving great interest in drug discovery and development that can be found as natural products or obtained by synthesis. Many derivatives of xanthones are chiral and associated with relevant biological activities, including antimicrobial. The aim of this review is to compile information about chiral derivatives of xanthones from natural sources and their synthesized examples with antimicrobial activity.

Keywords: antimicrobial; caged xanthones; chiral derivatives of xanthones; chirality; xanthones.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Xanthone scaffold.

Similar articles

Cited by

References

    1. Morehead M.S., Scarbrough C. Emergence of global antibiotic resistance. Prim. Care. 2018;45:467–484. doi: 10.1016/j.pop.2018.05.006. - DOI - PubMed
    1. Centers for Disease Control and Prevention, Antibiotic Use in the United States: Progress and Opportunities. [(accessed on 20 December 2018)]; Available online: https://www.cdc.gov/antibiotic-use/stewardship-report/pdf/stewardship-re....
    1. Morgan D., Okeke I., Laxminarayan R., Perencevich E., Weisenberg S. Non-prescription antimicrobial use worldwide: A systematic review. Lancet Infect Dis. 2011;11:692–701. doi: 10.1016/S1473-3099(11)70054-8. - DOI - PMC - PubMed
    1. Prestinaci F., Pezzotti P., Pantosti A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health. 2015;109:309–318. doi: 10.1179/2047773215Y.0000000030. - DOI - PMC - PubMed
    1. Li J., Liu S., Koh J.J., Zou H., Lakshminarayanan R., Bai Y., Pervushin K., Zhou L., Verma C., Beuerman R.W. A novel fragment based strategy for membrane active antimicrobials against MRSA. BBA. 2015;1848:1023–1031. doi: 10.1016/j.bbamem.2015.01.001. - DOI - PubMed

MeSH terms

LinkOut - more resources